Symbol: |
SPATS2L
|
Description: |
spermatogenesis associated, serine-rich 2-like [Source:HGNC Symbol;Acc:24574]
|
Location: |
Chr2:201170604-201343253[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:626
Gene |
Compound |
Gen_sig |
Exp_pattern |
SPATS2L |
NSC 726881 |
0.043 |
Up |
SPATS2L |
1-(3-diethylarsino-3-thio-2-methyl-1-oxopropyl)-L-proline |
0.007 |
Up |
SPATS2L |
6-(3-Aminopropyl)-5,6-dihydro-8,9-methylenedioxy-5,11-dioxo- 3-nitro-11H-indeno[1,2-c]isoquinoline Hydrochloride Salt |
0.003 |
Up |
SPATS2L |
Dasatinib |
0.001 |
Down |
SPATS2L |
NSC 732956 |
0.023 |
Up |
SPATS2L |
NSC 734385 |
0.032 |
Up |
SPATS2L |
NSC 734631 |
0.03 |
Up |
SPATS2L |
Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate |
0.036 |
Down |
SPATS2L |
4-(4-Chloro-phenyl)-7a-methyl-2,5-diphenyl-7aH-cyclopenta[b] pyran-7-one |
0.028 |
Up |
SPATS2L |
NSC 735333 |
0.035 |
Up |
SPATS2L |
6-(3-Bromopropyl)-5,6-dihydro-9-methyl-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline |
0.007 |
Up |
SPATS2L |
4-[(Z)-2-(5-nitro-2-furyl)ethenyl]-6-(4-phenylpiperazin-1-yl )-1,3,5-triazin-2-ylamine |
0.013 |
Up |
SPATS2L |
NSC 736104 |
0.015 |
Up |
SPATS2L |
NSC 736154 |
0.008 |
Up |
SPATS2L |
NSC 736188 |
0.002 |
Up |
Expression pattern: Sensitivity / Resistance
Total:42 Current:39
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:75
Total:5 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|